SEC Form 4 · accession 0001708138-18-000021
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Landry
Officer — SVP Finance & CFO
Period of report
Sep 10, 2018
Accepted (ET)
Sep 11, 2018 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 10, 2018 | F | 2,251 | $395.29 | D | 4,848 | D | |
| Common Stock | holding | — | — | — | 109 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.